Eric Johnson is a chemist and a researcher in environmental impacts. He was Editor in Chief for 16 years of an academic journal, Environmental Impact Assessment Review. According to Google Scholar, in the past 35 years he has published about 150 scientific articles which have been cited about two thousand times by other researchers. His main areas of research have been the agricultural, chemical and energy industries as well the biogenic carbon cycle.
He is Managing Director of Atlantic Consulting, which is based in Zurich, Switzerland. He is also a senior advisor to ecoinvent, the world’s largest knowledge base of life cycle assessment, for the topics of chemicals, oil and gas and plastics. ecoinvent provided some of the data for the analysis he will present today.
John Patterson is President of IKE Tech, a leading provider of identity verification (IDV), biometric authentication, and tokenization technology across a range of everyday consumer products. A passionate champion of Tobacco Harm Reduction, John has spent the last decade leading programs for some of the biggest brands in vapour technology including NJOY, JUUL and Aspire. As current Head of IKE Tech LLC, he is steering the organisation’s focus on solving some of the biggest industry challenges by utilizing innovative solutions to address youth access and illicit products.
Experienced Clinical Development and Drug Safety physician. Served in leadership positions in pharma companies for almost two decades, leading global clinical research and pharmacovigilance activities.
Ph.D. in biomedical engineering with 15+ years leading research and clinical trials. Extensive experience with international business operations and establishing collaborations. Excellent communication with scientific and lay audiences. Sound leadership skills in managing interdisciplinary teams across institutions with and without authority. Focus on problem-solving, conflict management, and creative solutions.
Kelly is a communications leader with more than 15 years of experience across all facets of pharmaceutical communications. In her current role as Head of Communications & Public Affairs for Servier Pharmaceuticals – she devises, manages and implements communications strategies across a range of internal and external channels and vehicles in support of corporate initiatives, pipeline and marketed products. She strives daily to meet patient needs and ensure their voice is heard.
As a seasoned genetic counselor, Tiara guides patient engagement throughout drug development and regulatory decision-making to ensure that patient and caregiver perspectives shape therapeutic objectives and inform benefit-risk thresholds. Her career has focused on the science of patient engagement, championing patient decision-making through initiatives and strategies that raise awareness of rare diseases, accelerate access to genetic testing resources, and communicate health data and balanced insights to targeted audiences
